Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant
Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Malignant Neoplasm Intervention: Procedure: Biospecimen Collection Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials